Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396785 · ClinicalTrials.gov registry record · Phase 3
Topical Antifungal Treatment for Tinea Pedis
A Phase 3 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 321
- Enrollment target
NCT01396785 is a Phase 3 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 321 participants.
The verdict
NCT01396785, a Phase 3 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 321 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.
Interventions
- DRUG Placebo
- DRUG 33525
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01396785
The ClinicalTrials.gov registry entry for NCT01396785 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 321 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medicis Global Service Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01396785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01396785 about?
NCT01396785 is a clinical study titled "Topical Antifungal Treatment for Tinea Pedis". The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.
What is the current status of trial NCT01396785?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 321 participants. The study started on 2011-07. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01396785?
The interventions under investigation include: Placebo (DRUG), 33525 (DRUG).
Who is sponsoring clinical trial NCT01396785?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.